Advanced search
Publication Cover
OncoImmunology Volume 8, 2019 - Issue 11
Submit an article Journal homepage
3,280
Views
60
CrossRef citations to date
0
Altmetric
Original Research

Irreversible electroporation of locally advanced pancreatic cancer transiently alleviates immune suppression and creates a window for antitumor T cell activation

Hester J. SchefferDepartments of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Vrije Universiteit-Cancer Center Amsterdam, Amsterdam, The NetherlandsView further author information
,
Anita G.M. StamDepartments of Medical Oncology, Amsterdam University Medical Center, Vrije Universiteit-Cancer Center Amsterdam, Amsterdam, The NetherlandsView further author information
,
Bart GeboersDepartments of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Vrije Universiteit-Cancer Center Amsterdam, Amsterdam, The NetherlandsORCID Iconhttps://orcid.org/0000-0002-8137-9299View further author information
ORCID Icon,
Laurien G.P.H. VroomenDepartments of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Vrije Universiteit-Cancer Center Amsterdam, Amsterdam, The NetherlandsView further author information
,
Alette RuarusDepartments of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Vrije Universiteit-Cancer Center Amsterdam, Amsterdam, The NetherlandsView further author information
,
Beaunelle de BruijnDepartments of Medical Oncology, Amsterdam University Medical Center, Vrije Universiteit-Cancer Center Amsterdam, Amsterdam, The NetherlandsView further author information
,
M. Petrousjka van den TolDepartments of Surgery, Amsterdam University Medical Center, Vrije Universiteit-Cancer Center Amsterdam, Amsterdam, The NetherlandsView further author information
,
Geert KazemierDepartments of Surgery, Amsterdam University Medical Center, Vrije Universiteit-Cancer Center Amsterdam, Amsterdam, The NetherlandsView further author information
,
Martijn R. MeijerinkDepartments of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Vrije Universiteit-Cancer Center Amsterdam, Amsterdam, The NetherlandsView further author information
&
Tanja D. de GruijlDepartments of Medical Oncology, Amsterdam University Medical Center, Vrije Universiteit-Cancer Center Amsterdam, Amsterdam, The NetherlandsCorrespondence[email protected]
View further author information
 show all
Article: 1652532 | Received 21 Feb 2019, Accepted 31 Jul 2019, Published online: 28 Aug 2019

Citations (60)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Tom van den Ende, Aiarpi Ezdoglian, Lisanne M. Baas, Joyce Bakker, Sinéad M. Lougheed, Micaela Harrasser, Cynthia Waasdorp, Mark I. van Berge Henegouwen, Maarten C.C.M. Hulshof, Nadia Haj Mohammad, Richard van Hillegersberg, Stella Mook, Conny J. van der Laken, Nicole C.T. van Grieken, Sarah Derks, Maarten F. Bijlsma, Hanneke W.M. van Laarhoven & Tanja D. de Gruijl. (2023) Longitudinal immune monitoring of patients with resectable esophageal adenocarcinoma treated with Neoadjuvant PD-L1 checkpoint inhibition. OncoImmunology 12:1.
Read now
Chaobin He, Shuxin Sun, Yu Zhang & Shengping Li. (2021) Irreversible Electroporation Plus Anti-PD-1 Antibody versus Irreversible Electroporation Alone for Patients with Locally Advanced Pancreatic Cancer. Journal of Inflammation Research 14, pages 4795-4807.
Read now
Chaobin He, Shuxin Sun, Yu Zhang & Shengping Li. (2021) Identification of Circulating Biomarkers and Construction of a Prognostic Signature for Survival Prediction in Locally Advanced Pancreatic Cancer After Irreversible Electroporation. Journal of Inflammation Research 14, pages 1689-1699.
Read now
Chaobin He, Shuxin Sun, Yu Zhang, Fengxiao Xie & Shengping Li. (2021) The role of irreversible electroporation in promoting M1 macrophage polarization via regulating the HMGB1-RAGE-MAPK axis in pancreatic cancer. OncoImmunology 10:1.
Read now

Articles from other publishers (56)

Ningning He & Jingting Jiang. (2024) Contribution of immune cells in synergistic anti-tumor effect of ablation and immunotherapy. Translational Oncology 40, pages 101859.
Crossref
Khan Mohammad Imran, Jessica Gannon, Holly A. Morrison, Juselyn D. Tupik, Benjamin Tintera, Margaret A. Nagai-Singer, Hannah Ivester, Justin Markov Madanick, Alissa Hendricks-Wenger, Kyungjun Uh, David T. Luyimbazi, Michael Edwards, Sheryl Coutermarsh-Ott, Kristin Eden, Christopher Byron, Sherrie Clark-Deener, Kiho Lee, Eli Vlaisavljevich & Irving C. Allen. (2023) Successful In Situ Targeting of Pancreatic Tumors in a Novel Orthotopic Porcine Model Using Histotripsy. Ultrasound in Medicine & Biology 49:11, pages 2361-2370.
Crossref
Yangyang Ma, Yanli Xing, Hongmei Li, Ting Yuan, Bing Liang, Rongrong Li, Jianyu Li, Zhonghai Li, Shuying Li & Lizhi Niu. (2023) Irreversible electroporation combined with chemotherapy and PD-1/PD-L1 blockade enhanced antitumor immunity for locally advanced pancreatic cancer. Frontiers in Immunology 14.
Crossref
Hengyu Li, Yu Zhou, Xiaoxia Guo, Qiwei Zhang & Xiaoyi Ding. (2023) The effects of irreversible electroporation triggering anti-tumor immunity and the value of its combination with immunotherapy. Journal of Interventional Medicine 6:3, pages 107-110.
Crossref
Luca G. Campana, Adil Daud, Francesco Lancellotti, Julio P. Arroyo, Rafael V. Davalos, Claudia Di Prata & Julie Gehl. (2023) Pulsed Electric Fields in Oncology: A Snapshot of Current Clinical Practices and Research Directions from the 4th World Congress of Electroporation. Cancers 15:13, pages 3340.
Crossref
Florentine E.F. Timmer, Bart Geboers, Hester J. Scheffer, Joyce Bakker, Alette H. Ruarus, Madelon Dijkstra, Susan van der Lei, Rianne Boon, Sanne Nieuwenhuizen, Bente A.T. van den Bemd, Evelien A.C. Schouten, Petrousjka M. van den Tol, Robbert S. Puijk, Jan J.J. de Vries, Tanja D. de Gruijl & Martijn R. Meijerink. (2023) Tissue Resistance Decrease during Irreversible Electroporation of Pancreatic Cancer as a Biomarker for the Adaptive Immune Response and Survival. Journal of Vascular and Interventional Radiology.
Crossref
Minhan Jiang, Steven Fiering & Qi Shao. (2023) Combining energy-based focal ablation and immune checkpoint inhibitors: preclinical research and clinical trials. Frontiers in Oncology 13.
Crossref
Matthew R Woeste, Rejeena Shrestha, Anne E Geller, Shu Li, Diego Montoya-Durango, Chuanlin Ding, Xiaoling Hu, Hong Li, Aaron Puckett, Robert A Mitchell, Traci Hayat, Min Tan, Yan Li, Kelly M McMasters, Robert C G Martin & Jun Yan. (2023) Irreversible electroporation augments β-glucan induced trained innate immunity for the treatment of pancreatic ductal adenocarcinoma. Journal for ImmunoTherapy of Cancer 11:4, pages e006221.
Crossref
Lin Xie & Zhiqiang Meng. (2023) Immunomodulatory effect of locoregional therapy in the tumor microenvironment. Molecular Therapy 31:4, pages 951-969.
Crossref
Hui Shen, Lin Wang, Yi Zhang, Guangliang Huang & Baoxian Liu. (2023) Knowledge mapping of image-guided tumor ablation and immunity: A bibliometric analysis. Frontiers in Immunology 14.
Crossref
Jayanth S Shankara Narayanan, Tomoko Hayashi, Suna Erdem, Sara McArdle, Herve Tiriac, Partha Ray, Minya Pu, Zbigniew Mikulski, Aaron Miller, Karen Messer, Dennis Carson, Stephen Schoenberger & Rebekah R White. (2023) Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic model. Journal for ImmunoTherapy of Cancer 11:1, pages e006133.
Crossref
Zachary P. Yeung & Madappa N. Kundranda. 2023. Pancreatic Cancer. Pancreatic Cancer 97 146 .
Jian Shen, Penglin Pan, Xiaoli Hu, Jun Zhao & Heshui Wu. (2022) Safety and Efficacy of Irreversible Electroporation in Locally Advanced Pancreatic Cancer: An Evaluation from a Surgeon’s Perspective. Cancers 14:22, pages 5677.
Crossref
Alaa Y. Bazeed, Candace M. Day & Sanjay Garg. (2022) Pancreatic Cancer: Challenges and Opportunities in Locoregional Therapies. Cancers 14:17, pages 4257.
Crossref
Yujue Wang, Tian’an Jiang, Liting Xie, Huiyang Wang, Jing Zhao, Lei Xu & Chengyu Fang. (2022) Effect of pulsed field ablation on solid tumor cells and microenvironment. Frontiers in Oncology 12.
Crossref
Wojciech Szlasa, Natalia Janicka, Natalia Sauer, Olga Michel, Bernadetta Nowak, Jolanta Saczko & Julita Kulbacka. (2022) Chemotherapy and Physical Therapeutics Modulate Antigens on Cancer Cells. Frontiers in Immunology 13.
Crossref
Tobias Freyberg Justesen, Adile Orhan, Hans Raskov, Christian Nolsoe & Ismail Gögenur. (2022) Electroporation and Immunotherapy—Unleashing the Abscopal Effect. Cancers 14:12, pages 2876.
Crossref
Argyrios Gyftopoulos, Ioannis A. Ziogas, Andrew S. Barbas & Dimitrios Moris. (2022) The Synergistic Role of Irreversible Electroporation and Chemotherapy for Locally Advanced Pancreatic Cancer. Frontiers in Oncology 12.
Crossref
Kelsey R. Murphy, Kenneth N. Aycock, Alayna N. Hay, John H. Rossmeisl, Rafael V. Davalos & Nikolaos G. Dervisis. (2022) High-frequency irreversible electroporation brain tumor ablation: exploring the dynamics of cell death and recovery. Bioelectrochemistry 144, pages 108001.
Crossref
Jonathan Garnier, Olivier Turrini, Anne-Sophie Chretien & Daniel Olive. (2022) Local Ablative Therapy Associated with Immunotherapy in Locally Advanced Pancreatic Cancer: A Solution to Overcome the Double Trouble?—A Comprehensive Review. Journal of Clinical Medicine 11:7, pages 1948.
Crossref
Zachary J. Senders & Robert C. G. MartinIIII. (2022) Intratumoral Immunotherapy and Tumor Ablation: A Local Approach with Broad Potential. Cancers 14:7, pages 1754.
Crossref
Khan Mohammad Imran, Margaret A. Nagai-Singer, Rebecca M. Brock, Nastaran Alinezhadbalalami, Rafael V. Davalos & Irving Coy Allen. (2022) Exploration of Novel Pathways Underlying Irreversible Electroporation Induced Anti-Tumor Immunity in Pancreatic Cancer. Frontiers in Oncology 12.
Crossref
Nana Zhang, Zhuoqun Li, Xuan Han, Ziyu Zhu, Zhujun Li, Yan Zhao, Zhijun Liu & Yi Lv. (2022) Irreversible Electroporation: An Emerging Immunomodulatory Therapy on Solid Tumors. Frontiers in Immunology 12.
Crossref
Zetian Gao, Qiubo Zhang, Xie Zhang & Yufei Song. (2022) Advance of T regulatory cells in tumor microenvironment remodeling and immunotherapy in pancreatic cancer. European Journal of Inflammation 20, pages 1721727X2210929.
Crossref
Benjamin Eigl, Andreas Andreou, Matthias Peterhans, Stefan Weber & Beat Gloor. 2021. Challenges in Pancreatic Cancer. Challenges in Pancreatic Cancer.
Melvin F. Lorenzo, Sabrina N. Campelo, Julio P. Arroyo, Kenneth N. Aycock, Jonathan Hinckley, Christopher B. Arena, John H. RossmeislJr.Jr. & Rafael V. Davalos. (2021) An Investigation for Large Volume, Focal Blood-Brain Barrier Disruption with High-Frequency Pulsed Electric Fields. Pharmaceuticals 14:12, pages 1333.
Crossref
Xiaoxia Guo, Fang Du, Qin Liu, Yan Guo, Qingbing Wang, Wei Huang, Zhongmin Wang, Xiaoyi Ding & Zhiyuan Wu. (2021) Immunological effect of irreversible electroporation on hepatocellular carcinoma. BMC Cancer 21:1.
Crossref
Helena Cindric, Panchatcharam Mariappan, Lukas Beyer, Philipp Wiggermann, Michael Moche, Damijan Miklavcic & Bor Kos. (2021) Retrospective Study for Validation and Improvement of Numerical Treatment Planning of Irreversible Electroporation Ablation for Treatment of Liver Tumors. IEEE Transactions on Biomedical Engineering 68:12, pages 3513-3524.
Crossref
Brandon J. Burbach, Stephen D. O’Flanagan, Qi Shao, Katharine M. Young, Joseph R. Slaughter, Meagan R. Rollins, Tami Jo L. Street, Victoria E. Granger, Lalit. K. Beura, Samira M. Azarin, Satish Ramadhyani, Bruce R. Forsyth, John C. Bischof & Yoji Shimizu. (2021) Irreversible electroporation augments checkpoint immunotherapy in prostate cancer and promotes tumor antigen-specific tissue-resident memory CD8+ T cells. Nature Communications 12:1.
Crossref
Tina Batista Napotnik, Tamara Polajžer & Damijan Miklavčič. (2021) Cell death due to electroporation – A review. Bioelectrochemistry 141, pages 107871.
Crossref
Guo Tian, Jiajia Guan, Yanhua Chu, Qiyu Zhao & Tian’an Jiang. (2021) Immunomodulatory Effect of Irreversible Electroporation Alone and Its Cooperating With Immunotherapy in Pancreatic Cancer. Frontiers in Oncology 11.
Crossref
Alissa Hendricks-Wenger, Jacqueline Sereno, Jessica Gannon, Allison Zeher, Rebecca M. Brock, Natalie Beitel-White, Alexander Simon, Rafael V. Davalos, Sheryl Coutermarsh-Ott, Eli Vlaisavljevich & Irving Coy Allen. (2021) Histotripsy Ablation Alters the Tumor Microenvironment and Promotes Immune System Activation in a Subcutaneous Model of Pancreatic Cancer. IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control 68:9, pages 2987-3000.
Crossref
Florentine E. F. Timmer, Bart Geboers, Sanne Nieuwenhuizen, Madelon Dijkstra, Evelien A. C. Schouten, Robbert S. Puijk, Jan J. J. de Vries, M. Petrousjka van den Tol, Anna M. E. Bruynzeel, Mirte M. Streppel, Johanna W. Wilmink, Hans J. van der Vliet, Martijn R. Meijerink, Hester J. Scheffer & Tanja D. de Gruijl. (2021) Pancreatic Cancer and Immunotherapy: A Clinical Overview. Cancers 13:16, pages 4138.
Crossref
Bart Geboers, Florentine Timmer, Alette Ruarus, Johanna Pouw, Evelien Schouten, Joyce Bakker, Robbert Puijk, Sanne Nieuwenhuizen, Madelon Dijkstra, M. van den Tol, Jan de Vries, Daniela Oprea-Lager, C. Menke-van der Houven van Oordt, Hans van der Vliet, Johanna Wilmink, Hester Scheffer, Tanja de Gruijl & Martijn Meijerink. (2021) Irreversible Electroporation and Nivolumab Combined with Intratumoral Administration of a Toll-Like Receptor Ligand, as a Means of In Vivo Vaccination for Metastatic Pancreatic Ductal Adenocarcinoma (PANFIRE-III). A Phase-I Study Protocol. Cancers 13:15, pages 3902.
Crossref
Rebekah R. White, James D. Murphy & Robert C. G. Martin. (2021) The Landmark Series: Locally Advanced Pancreatic Cancer and Ablative Therapy Options. Annals of Surgical Oncology 28:8, pages 4173-4180.
Crossref
Bathiya Ratnayake, Dhya Al-Leswas, Ghazaleh Mohammadi-Zaniani, Peter Littler, Gourab Sen, Derek Manas & Sanjay Pandanaboyana. (2021) Margin Accentuation Irreversible Electroporation in Stage III Pancreatic Cancer: A Systematic Review. Cancers 13:13, pages 3212.
Crossref
Florentine E.F. Timmer, Bart Geboers, Sanne Nieuwenhuizen, Evelien A.C. Schouten, Madelon Dijkstra, Jan J.J. de Vries, M. Petrousjka van den Tol, Tanja D. de Gruijl, Hester J. Scheffer & Martijn R. Meijerink. (2021) Locally Advanced Pancreatic Cancer: Percutaneous Management Using Ablation, Brachytherapy, Intra-arterial Chemotherapy, and Intra-tumoral Immunotherapy. Current Oncology Reports 23:6.
Crossref
Alissa Hendricks-Wenger, Ruby Hutchison, Eli Vlaisavljevich & Irving Coy Allen. (2021) Immunological Effects of Histotripsy for Cancer Therapy. Frontiers in Oncology 11.
Crossref
Eva Pirc, Damijan Miklavčič, Katja Uršič, Gregor Serša & Matej Reberšek. (2021) High-Frequency and High-Voltage Asymmetric Bipolar Pulse Generator for Electroporation Based Technologies and Therapies. Electronics 10:10, pages 1203.
Crossref
Zihao Dai, Zongren Wang, Kai Lei, Junbin Liao, Zhenwei Peng, Manxia Lin, Ping Liang, Jie Yu, Sui Peng, Shuling Chen & Ming Kuang. (2021) Irreversible electroporation induces CD8+ T cell immune response against post-ablation hepatocellular carcinoma growth. Cancer Letters 503, pages 1-10.
Crossref
Wooil Kwon, Alexander Thomas & Michael D. Kluger. (2021) Irreversible electroporation of locally advanced pancreatic cancer. Seminars in Oncology 48:1, pages 84-94.
Crossref
Evan K. Massaro, Ishan Goswami, Scott S. Verbridge & Michael R. von Spakovsky. (2021) Electro-chemo-mechanical model to investigate multi-pulse electric-field-driven integrin clustering. Bioelectrochemistry 137, pages 107638.
Crossref
Roberto Salvia, Laura Addari & Salvatore Paiella. 2021. Textbook of Pancreatic Cancer. Textbook of Pancreatic Cancer 1267 1280 .
Govindarajan Narayanan, Antonio Ucar, Ripal T. Gandhi, Arian Nasiri, Prasuna Inampudi, Nicole M. Wilson & Horacio Jose Asbun. (2020) Emerging Ablative and Transarterial Therapies for Pancreatic Cancer. Digestive Disease Interventions 04:04, pages 389-394.
Crossref
M. H. Sodergren, N. Mangal, H. Wasan, A. Sadanandam, V. P. Balachandran, L. R. Jiao & N. Habib. (2020) Immunological combination treatment holds the key to improving survival in pancreatic cancer. Journal of Cancer Research and Clinical Oncology 146:11, pages 2897-2911.
Crossref
Eun-Jin Go, Hannah Yang, Hong Jae Chon, DaSom Yang, WonHyoung Ryu, Dong-Hyun Kim, Dong Keun Han, Chan Kim & Wooram Park. (2020) Combination of Irreversible Electroporation and STING Agonist for Effective Cancer Immunotherapy. Cancers 12:11, pages 3123.
Crossref
Mao Lin, Xiaoyan Zhang, Shuzhen Liang, Haihua Luo, Mohammed Alnaggar, Aihua Liu, Zhinan Yin, Jibing Chen, Lizhi Niu & Yong Jiang. (2020) Irreversible electroporation plus allogenic Vγ9Vδ2 T cells enhances antitumor effect for locally advanced pancreatic cancer patients. Signal Transduction and Targeted Therapy 5:1.
Crossref
Aleksander Kiełbik, Wojciech Szlasa, Jolanta Saczko & Julita Kulbacka. (2020) Electroporation-Based Treatments in Urology. Cancers 12:8, pages 2208.
Crossref
Ling Qian, Yehua Shen, Jing Xie & Zhiqiang Meng. (2020) Immunomodulatory effects of ablation therapy on tumors: Potentials for combination with immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1874:1, pages 188385.
Crossref
Tamara Polajzer, Tomaz Jarm & Damijan Miklavcic. (2020) Analysis of damage-associated molecular pattern molecules due to electroporation of cells in vitro. Radiology and Oncology 54:3, pages 317-328.
Crossref
Florentine E.F. Timmer, Bart Geboers, Alette H. Ruarus, Evelien A.C. Schouten, Sanne Nieuwenhuizen, Robbert S. Puijk, Jan J.J. de Vries, Martijn R. Meijerink & Hester J. Scheffer. (2020) Irreversible Electroporation for Locally Advanced Pancreatic Cancer. Techniques in Vascular and Interventional Radiology 23:2, pages 100675.
Crossref
Chaobin He, Xin Huang, Yu Zhang, Xiaojun Lin & Shengping Li. (2020) T‐cell activation and immune memory enhancement induced by irreversible electroporation in pancreatic cancer. Clinical and Translational Medicine 10:2.
Crossref
Bart Geboers, Hester J. Scheffer, Philip M. Graybill, Alette H. Ruarus, Sanne Nieuwenhuizen, Robbert S. Puijk, Petrousjka M. van den Tol, Rafael V. Davalos, Boris Rubinsky, Tanja D. de Gruijl, Damijan Miklavčič & Martijn R. Meijerink. (2020) High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy. Radiology 295:2, pages 254-272.
Crossref
Francisco Pelaez, Qi Shao, Pegah Ranjbartehrani, Tiffany Lam, Hak Rae Lee, Stephen O’Flanagan, Abby Silbaugh, John C. Bischof & Samira M. Azarin. (2020) Optimizing Integrated Electrode Design for Irreversible Electroporation of Implanted Polymer Scaffolds. Annals of Biomedical Engineering 48:4, pages 1230-1240.
Crossref
Kenneth N. AycockRafael V. Davalos. (2019) Irreversible Electroporation: Background, Theory, and Review of Recent Developments in Clinical Oncology. Bioelectricity 1:4, pages 214-234.
Crossref
N. Beitel-White, R. C. G. Martin, Y. Li, R. M. Brock, I. C. Allen & R. V. Davalos. (2019) Real-time prediction of patient immune cell modulation during irreversible electroporation therapy. Scientific Reports 9:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.